Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS.

Cu(II)ATSM - Collaborative Medicinal Development

http://www.ncbi.nlm.nih.gov/pubmed/38467696

Anthony R White; Ashley I Bush; Bence Paul; Blaine R Roberts; Catriona A McLean; Dominic J Hare; James B W Hilton; Jeffrey R Liddell; Joseph S Beckman; Kai Kysenius; Paul S Donnelly; Peter J Crouch; Stephen W Mercer

Mar 12, 2024